Your browser doesn't support javascript.
loading
Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
Kerbrat, Anne; Gros, Charley; Badji, Atef; Bannier, Elise; Galassi, Francesca; Combès, Benoit; Chouteau, Raphaël; Labauge, Pierre; Ayrignac, Xavier; Carra-Dalliere, Clarisse; Maranzano, Josefina; Granberg, Tobias; Ouellette, Russell; Stawiarz, Leszek; Hillert, Jan; Talbott, Jason; Tachibana, Yasuhiko; Hori, Masaaki; Kamiya, Kouhei; Chougar, Lydia; Lefeuvre, Jennifer; Reich, Daniel S; Nair, Govind; Valsasina, Paola; Rocca, Maria A; Filippi, Massimo; Chu, Renxin; Bakshi, Rohit; Callot, Virginie; Pelletier, Jean; Audoin, Bertrand; Maarouf, Adil; Collongues, Nicolas; De Seze, Jérôme; Edan, Gilles; Cohen-Adad, Julien.
Affiliation
  • Kerbrat A; NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montreal, Montreal, Canada.
  • Gros C; CHU Rennes, Neurology department, Empenn U 1128 Inserm, CIC1414 Inserm, Rennes, France.
  • Badji A; NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montreal, Montreal, Canada.
  • Bannier E; NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montreal, Montreal, Canada.
  • Galassi F; Department of Neurosciences, Faculty of Medicine, Université de Montréal, QC, Canada.
  • Combès B; CHU Rennes, Radiology department, Rennes, France.
  • Chouteau R; Univ Rennes, Inria, CNRS, Inserm, IRISA UMR 6074, Empenn U1128, Rennes, France.
  • Labauge P; Univ Rennes, Inria, CNRS, Inserm, IRISA UMR 6074, Empenn U1128, Rennes, France.
  • Ayrignac X; Univ Rennes, Inria, CNRS, Inserm, IRISA UMR 6074, Empenn U1128, Rennes, France.
  • Carra-Dalliere C; CHU Rennes, Neurology department, Empenn U 1128 Inserm, CIC1414 Inserm, Rennes, France.
  • Maranzano J; MS Unit, Department of Neurology, CHU Montpellier, Montpellier, France.
  • Granberg T; MS Unit, Department of Neurology, CHU Montpellier, Montpellier, France.
  • Ouellette R; MS Unit, Department of Neurology, CHU Montpellier, Montpellier, France.
  • Stawiarz L; McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada.
  • Hillert J; University of Quebec in Trois-Rivieres, Quebec, Canada.
  • Talbott J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Tachibana Y; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Hori M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Kamiya K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Chougar L; Department of Radiology and Biomedical Imaging, Zuckerberg San Francisco General Hospital, University of California, San Francisco, CA, USA.
  • Lefeuvre J; National Institute of Radiological Sciences, QST, Chiba, Chiba, Japan.
  • Reich DS; Toho University Omori Medical Center, Tokyo, Japan.
  • Nair G; Toho University Omori Medical Center, Tokyo, Japan.
  • Valsasina P; Department of Neuroradiology, La Pitié Salpêtrière Hospital, Paris, France.
  • Rocca MA; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Maryland, USA.
  • Filippi M; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Maryland, USA.
  • Chu R; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Maryland, USA.
  • Bakshi R; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Callot V; Vita-Salute San Raffaele University, Milan, Italy.
  • Pelletier J; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Audoin B; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Maarouf A; Vita-Salute San Raffaele University, Milan, Italy.
  • Collongues N; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • De Seze J; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Edan G; AP-HM, Pôle d'imagerie médicale, Hôpital de la Timone, CEMEREM, Marseille, France.
  • Cohen-Adad J; Aix-Marseille Univ, CNRS, CRMBM, Marseille, France.
Brain ; 143(7): 2089-2105, 2020 07 01.
Article in En | MEDLINE | ID: mdl-32572488
ABSTRACT
Despite important efforts to solve the clinico-radiological paradox, correlation between lesion load and physical disability in patients with multiple sclerosis remains modest. One hypothesis could be that lesion location in corticospinal tracts plays a key role in explaining motor impairment. In this study, we describe the distribution of lesions along the corticospinal tracts from the cortex to the cervical spinal cord in patients with various disease phenotypes and disability status. We also assess the link between lesion load and location within corticospinal tracts, and disability at baseline and 2-year follow-up. We retrospectively included 290 patients (22 clinically isolated syndrome, 198 relapsing remitting, 39 secondary progressive, 31 primary progressive multiple sclerosis) from eight sites. Lesions were segmented on both brain (T2-FLAIR or T2-weighted) and cervical (axial T2- or T2*-weighted) MRI scans. Data were processed using an automated and publicly available pipeline. Brain, brainstem and spinal cord portions of the corticospinal tracts were identified using probabilistic atlases to measure the lesion volume fraction. Lesion frequency maps were produced for each phenotype and disability scores assessed with Expanded Disability Status Scale score and pyramidal functional system score. Results show that lesions were not homogeneously distributed along the corticospinal tracts, with the highest lesion frequency in the corona radiata and between C2 and C4 vertebral levels. The lesion volume fraction in the corticospinal tracts was higher in secondary and primary progressive patients (mean = 3.6 ± 2.7% and 2.9 ± 2.4%), compared to relapsing-remitting patients (1.6 ± 2.1%, both P < 0.0001). Voxel-wise analyses confirmed that lesion frequency was higher in progressive compared to relapsing-remitting patients, with significant bilateral clusters in the spinal cord corticospinal tracts (P < 0.01). The baseline Expanded Disability Status Scale score was associated with lesion volume fraction within the brain (r = 0.31, P < 0.0001), brainstem (r = 0.45, P < 0.0001) and spinal cord (r = 0.57, P < 0.0001) corticospinal tracts. The spinal cord corticospinal tracts lesion volume fraction remained the strongest factor in the multiple linear regression model, independently from cord atrophy. Baseline spinal cord corticospinal tracts lesion volume fraction was also associated with disability progression at 2-year follow-up (P = 0.003). Our results suggest a cumulative effect of lesions within the corticospinal tracts along the brain, brainstem and spinal cord portions to explain physical disability in multiple sclerosis patients, with a predominant impact of intramedullary lesions.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pyramidal Tracts / Brain / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Brain Year: 2020 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: Pyramidal Tracts / Brain / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Brain Year: 2020 Type: Article Affiliation country: Canada